Investors & Media

Transformative science, targeted medicines

Blueprint Medicines, a Sanofi company, is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

SEC Filings

SEC Filings

Search
Filing date Form Description View
SCHEDULE 13G/A SCHEDULE 13G/A - Description View HTML
0002052113-25-001478.pdf
0002052113-25-001478.rtf
0002052113-25-001478.xls
4 Statement of changes in beneficial ownership of securities View HTML
0001415889-25-009959.pdf
0001415889-25-009959.rtf
0001415889-25-009959.xls
144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing View HTML
0001950047-25-002289.pdf
0001950047-25-002289.rtf
0001950047-25-002289.xls
4 Statement of changes in beneficial ownership of securities View HTML
0001415889-25-009027.pdf
0001415889-25-009027.rtf
0001415889-25-009027.xls
144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing View HTML
0001968582-25-000234.pdf
0001968582-25-000234.rtf
0001968582-25-000234.xls
4 Statement of changes in beneficial ownership of securities View HTML
0001415889-25-008211.pdf
0001415889-25-008211.rtf
0001415889-25-008211.xls
4 Statement of changes in beneficial ownership of securities View HTML
0001415889-25-008112.pdf
0001415889-25-008112.rtf
0001415889-25-008112.xls
4 Statement of changes in beneficial ownership of securities View HTML
0001415889-25-007381.pdf
0001415889-25-007381.rtf
0001415889-25-007381.xls
4 Statement of changes in beneficial ownership of securities View HTML
0001415889-25-007389.pdf
0001415889-25-007389.rtf
0001415889-25-007389.xls
4 Statement of changes in beneficial ownership of securities View HTML
0001415889-25-007384.pdf
0001415889-25-007384.rtf
0001415889-25-007384.xls